Diagnostic accuracy of urine-based HPV DNA testing for cervical cancer screening: A systematic literature review
DOI: https://doi.org/10.33024/min.v9i7.4261
Cervical Cancer Diagnostic Accuracy HPV DNA Testing Urine-Based Screening
Abstract
Background: Cervical cancer remains a major global health challenge, particularly in low- and middle-income countries where screening uptake is limited. Clinician-collected cervical HPV testing is the current reference standard, yet conventional sampling procedures are often invasive, uncomfortable, and stigmatized, reducing acceptability among under-screened women. Urine-based HPV DNA testing has therefore emerged as a promising non-invasive alternative.
Purpose: To critically synthesize and appraise existing evidence on the diagnostic accuracy of urine-based HPV DNA testing—specifically its sensitivity, specificity, and concordance—as well as the methodological factors influencing these metrics, in comparison with clinician-collected cervical HPV DNA samples for cervical cancer screening.
Method: This systematic review, conducted in accordance with PRISMA 2020 guidelines, synthesized evidence from PubMed, Scopus, and ScienceDirect published between 2016 and 2026. Thirty eligible studies were included from 455 identified records, all evaluating the diagnostic accuracy of urine-based HPV DNA testing compared with clinician-collected cervical samples.
Results: Findings revealed moderate-to-high concordance, with sensitivity ranging from 44% to over 95% and consistently high specificity. Superior diagnostic performance was observed in studies employing first-void urine collection and validated PCR-based assays, while methodological heterogeneity in collection procedures, preservation methods, and assay platforms remained evident.
Conclusion: Urine-based HPV DNA testing offers a feasible, non-invasive approach to expand cervical cancer screening, particularly for under-screened populations. However, methodological standardization and large-scale validation are essential before adoption as a primary screening strategy.
Downloads
References
Aimagambetova, G., Atageldiyeva, K., Marat, A., Suleimenova, A., Issa, T., Raman, S., Huang, T., Ashimkhanova, A., Aron, S., Dongo, A., Iztleuov, Y., Shamkeeva, S., & Azizan, A. (2024). Comparison of diagnostic accuracy and acceptability of self-sampling devices for human Papillomavirus detection: A systematic review. Preventive Medicine Reports, 38, 102590. https://doi.org/https://doi.org/10.1016/j.pmedr.2024.102590
Andrijono, A., Wulandari, D., Widyahening, I. S., Mahardhika, D., Nurainy, N., Sari, R. M., Soetomo, I., & Utama, R. (2023). Diagnostic performance of urine-based HPV-DNA test (CerviScan, Bio Farma) as Cervical Cancer screening tool in adult women. Indonesian Journal of Obstetrics and Gynecology, 161-165. https://doi.org/10.32771/inajog.v11i3.1968
Asciutto, K. C., Henningsson, A. J., Borgfeldt, H., Darlin, L., & Borgfeldt, C. (2017). Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the cobas 4800 HPV test. Anticancer Research, 37(8), 4183–4187. https://doi.org/10.21873/anticanres.11807
Bose, S., Mandal, R., Sengupta, S., Dutta, S., Abraham, P., Muwonge, R., Lucas, E., Panda, C. K., Palaniraja, S., Rol, M., Chakrabarti, J., & Basu, P. (2026). Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting. BMJ Global Health, 11(1). https://doi.org/10.1136/bmjgh-2025-021707
Buchegger, K., Viscarra, T., Andana, A., Ili, C., López, J., Zanella, L., Carmona-López, M. I., Fernández, J. J., Espinel, I. C., Sánchez, R., Roa, J. C., & Brebi, P. (2018). Detection and genotyping of human papillomavirus virus (HPV): a comparative analysis of clinical performance in cervical and urine samples in Chilean women. International Journal of Clinical and Experimental Pathology, 11(11), 5413–5421.
Combita, A. L., Gheit, T., Gonzalez, P., Puerto, D., Murillo, R. H., Montoya, L., Vorsters, A., Van Keer, S., Van Dammeaa, P., Tommasino, M., Hernandez-Suarez, G., Sanchez, L., Herrero, R., & Wiesner, C. (2016). Comparison between Urine and Cervical Samples for HPV DNA detection and typing in young women in Colombia. Cancer Prevention Research, 9(9), 766–771. https://doi.org/10.1158/1940-6207.CAPR-16-0038
Davies, J. C., Sargent, A., Pinggera, E., Carter, S., Gilham, C., Sasieni, P., & Crosbie, E. J. (2024). Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial. BJOG: An International Journal of Obstetrics and Gynaecology, 131(11), 1456–1464. https://doi.org/10.1111/1471-0528.17831
Du, H., Dai, W., Wu, D., Liu, Y., Xiao, A., Hou, J., Huang, B., Zhang, W., Bao, J., Huang, Q., Geng, L., Yang, Q., Li, C., & Wu, R. (2025). Expanding access to cervical cancer screening: The performance of self-sampled urine HPV testing. International Journal of Infectious Diseases, 161, 108175. https://doi.org/https://doi.org/10.1016/j.ijid.2025.108175
El-Zein, M., Kassam, P., Alhamlan, F., Zafar, N., Abdelmoula, B., Fadhil, I., Nedjai, B., Selmouni, F., & Basu, P. (2026). Toward cervical cancer prevention and elimination in the Eastern Mediterranean Region: Current landscape and opportunities for evidence-based action. Preventive Medicine, 208, 108549. https://doi.org/10.1016/j.ypmed.2026.108549
Ertik, F. C., Kampers, J., Hülse, F., Stolte, C., Böhmer, G., Hillemanns, P., & Jentschke, M. (2021). Cocoss-trial: concurrent comparison of self-sampling devices for HPV-detection. International Journal of Environmental Research and Public Health, 18(19), 10388. https://doi.org/10.3390/ijerph181910388
Hernandez, B. Y., Tareg, A. C., Reichhardt, M., Agapito, A., Zhu, X., Sy, A., Yuji, A., Killeen, J., Chan, O., & Buenconsejo-Lum, L. E. (2018). Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population. Journal of Global Health Reports, 2.
Hwang, S. H., Shin, H. Y., Lee, D. O., Sung, N. Y., Lee, B., Lee, D. H., & Jun, J. K. (2018). A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening. Scientific reports, 8(1), 9015. https://doi.org/10.1038/s41598-018-27390-5
Intan, N. S., Utama, R., Wulandari, D., Wisdharilla, R., Khanza, S. M., Ramadhan, M. R., Widyahening, I. S., Nurainy, N., Sari, R. M., & Andrijono. (2025). Urinary detection of high-risk HPV DNA to enhance cervical cancer screening in developing countries. Microbiology Spectrum, 13(9). https://doi.org/10.1128/spectrum.01938-24
Kaoma, M., Olayemi, O., Mwaba, M. H., & Sikwewa, K. (2023). Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia. BMC Women’s Health, 23(1), 62. https://doi.org/10.1186/s12905-023-02212-7
Khunamornpong, S., Settakorn, J., Sukpan, K., Lekawanvijit, S., Katruang, N., & Siriaunkgul, S. (2016). Comparison of human papillomavirus detection in urine and cervical samples using high‐risk HPV DNA testing in northern Thailand. Obstetrics and Gynecology International, 2016(1), 6801491. https://doi.org/10.1155/2016/6801491
Latsuzbaia, A., Martinelli, M., Giubbi, C., Cuschieri, K., Elasifer, H., Iacobone, A. D., Bottari, F., Piana, A. F., Pietri, R., Tisi, G., Odicino, F., Cocuzza, C. E., & Arbyn, M. (2024). Clinical accuracy of OncoPredict HPV Quantitative Typing (QT) assay on self-samples. Journal of Clinical Virology, 175, 105737. https://doi.org/https://doi.org/10.1016/j.jcv.2024.105737
Manjeshwar, S., Kojima, N., Tsang, E., Pereira, D., Silva, E., Duong, H., Chao, F., Marshak, D. R., Chiu, R. Y. T., & Klausner, J. D. (2026). Performance of a novel, urine-based test for the detection of cervical human papillomavirus infection. Journal of Clinical Microbiology, 64(2), e0131825. https://doi.org/10.1128/jcm.01318-25
Marcus, J. Z., Abedin, Y., Pierz, A. J., Taveras, Y., Sollecito, C. C., Parmar, H., Burk, R. D., & Castle, P. E. (2021). A Pilot Study of Human Papillomavirus Detection in Urine Using a Novel Nucleic Acid Amplification Test. Journal of Applied Laboratory Medicine, 6(2), 474–479. https://doi.org/10.1093/jalm/jfaa238
Marhash, A. D., Al-Mayah, Q. S., & Al-Kazaaly, E. A. A. (2018). Detection and phylogenetic analysis of human papilloma virus in urine from a sample of Iraqi women with vaginal discharge. Journal of Pure and Applied Microbiology, 12(4), 2183–2192. https://doi.org/10.22207/JPAM.12.4.57
Mizuno, M., Kamio, M., Sakihama, M., Yanazume, S., Togami, S., Kakizoe, T., & Kobayashi, H. (2025). The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women. Gynecologic and Obstetric Investigation, 90(2), 143–152. https://doi.org/10.1159/000541641
Neita, L. H. S., Mahecha, E. G., Valero, M. G. H., Suárez, J. M., Rojas, J. P. C., Villalba, G. E. C., & López, L. X. R. (2026). HPV detection in first void urine and cervicovaginal samples: comparative study and analysis of associated factors in women from Tunja, Colombia. Preventive Medicine Reports, 62, 103393. https://doi.org/https://doi.org/10.1016/j.pmedr.2026.103393
Nilyanimit, P., Chaithongwongwatthana, S., Oranratanaphan, S., Poudyal, N., Excler, J.-L., Lynch, J., Vongpunsawad, S., & Poovorawan, Y. (2024). Comparable detection of HPV using real-time PCR in paired cervical samples and concentrated first-stream urine collected with Colli-Pee device. Diagnostic Microbiology and Infectious Disease, 108(3), 116160. https://doi.org/https://doi.org/10.1016/j.diagmicrobio.2023.116160
Purwar, S., Gupta, S., John, J. H., Gupta, P., & Halder, A. (2023). Study to Determine Concordance between High-Risk Human Papilloma Virus DNA Detection in Self Collected First Voided Urine Samples and Health-Care Worker Collected Cervical Samples in a Subset of Women with Proven Histopathological Precancerous and Cancero. Journal of Mid-Life Health, 14(1), 8–14. https://doi.org/10.4103/jmh.jmh_251_22
Sabeena, S., Kuriakose, S., Binesh, D., Abdulmajeed, J., Dsouza, G., Ramachandran, A., Vijaykumar, B., Aswathyraj, S., Devadiga, S., Ravishankar, N., & Arunkumar, G. (2019). The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings. Asian Pacific Journal of Cancer Prevention : APJCP, 20(8), 2409–2413. https://doi.org/10.31557/APJCP.2019.20.8.2409
Sharipova, I. P., Mirzaev, U. K., Kasimova, R. I., Yoshinaga, Y., Shrapov, S. M., Suyarkulova, D. T., & Musabaev, E. I. (2024). Optimizing Human Papillomavirus (HPV) Screening: Urine Sample Analysis and Associated Factors in Uzbekistan. Cureus, 16(9), e69816. https://doi.org/10.7759/cureus.69816
Shih, Y.-H., Sun, L., Hsu, S.-T., Chen, M.-J., & Lu, C.-H. (2023). Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples? International Journal of Women’s Health, 15, 1421–1429. https://doi.org/10.2147/IJWH.S416520
Shin, H. Y., Lee, B., Hwang, S. H., Lee, D. O., Sung, N. Y., Park, J. Y., & Jun, J. K. (2019). Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling. Journal of Gynecologic Oncology, 30(5), e76. https://doi.org/10.3802/jgo.2019.30.e76
Téblick, L., Van Keer, S., De Smet, A., Van Damme, P., Laeremans, M., Rios Cortes, A., Beyers, K., Vankerckhoven, V., Matheeussen, V., Mandersloot, R., Floore, A., Meijer, C. J. L. M., Steenbergen, R. D. M., & Vorsters, A. (2021). Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine. Molecules (Basel, Switzerland), 26(7). https://doi.org/10.3390/molecules26071989
Tranberg, M., Jensen, J. S., Bech, B. H., & Andersen, B. (2020). Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays. BMC Infectious Diseases, 20(1). https://doi.org/10.1186/s12879-020-05663-7
Tranberg, M., Van Keer, S., Jensen, J. S., Nørgaard, P., Gustafson, L. W., Hammer, A., Bor, P., Binderup, K. O., Blach, C., & Vorsters, A. (2025). High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality—a Danish diagnostic test accuracy study. BMC Medicine, 23(1). https://doi.org/10.1186/s12916-025-04149-0
Uyar, N. Y., Bodur, H., Erdem, M. O., Altinisik, I. A. K., Aksoy, E., Polat, T., Demir, F., Acar, O., Aksakal, B., Alizade, G., Nadirova, N., Apa, A., Can, O., & Kocagoz, T. (2025). Concentrated urine as an alternative to cervical smear samples enabling easy screening of HPV in large populations. Journal of Infection and Public Health, 18(10), 102857. https://doi.org/https://doi.org/10.1016/j.jiph.2025.102857
van den Borst, E., Vanden Broeck, D., De Sutter, P., Donders, G., Doyen, J., Tjalma, W., Weyers, S., Arbyn, M., Van Keer, S., & Latsuzbaia, A. (2025). EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol. Gynecologic Oncology, 202, 14–23. https://doi.org/https://doi.org/10.1016/j.ygyno.2025.08.018
Van Keer, S., Latsuzbaia, A., Vanden Broeck, D., De Sutter, P., Donders, G., Doyen, J., Tjalma, W. A. A., Weyers, S., Arbyn, M., & Vorsters, A. (2025). Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples. The Journal of Molecular Diagnostics, 27(5), 419–429. https://doi.org/https://doi.org/10.1016/j.jmoldx.2025.02.004
Yamazaki, H., Wada, T., Asano, H., Fujita, H., Okamoto, K., & Watari, H. (2021). Comparison between urine and cervical high-risk hpv tests for japanese women with asc-us. Diagnostics, 11(10). https://doi.org/10.3390/diagnostics11101895
Yang, H., Luo, Z.-Y., Lin, F., Li, L.-J., Lu, M., Xie, L.-X., & Yang, L.-Y. (2023). Comparison of Urine and Genital Samples for Detecting Human Papillomavirus (HPV) in Clinical Patients. Obstetrics and Gynecology International, 2023, 7483783. https://doi.org/10.1155/2023/7483783
Young, A. P., O’Dwyer, M. C., Smith, R., Chen, D., Sen, A., Walline, H. M., & Harper, D. M. (2025). A United States study of self-collected urine vs clinician-collected cervical sample for HPV and cervical intraepithelial neoplasia grade two or worse detection: Cross-sectional agreement and diagnostic accuracy study. Preventive Medicine Reports, 58, 103222. https://doi.org/https://doi.org/10.1016/j.pmedr.2025.103222
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Firdaus Cahya Saputra, Dwi Sarwani Sri Rejeki, Siwi Pramatama Mars Wijayanti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
